Client Background

MedVision Diagnostics, a cutting-edge medical device company, developed a revolutionary non-invasive imaging technology for early detection of cardiovascular diseases.

Challenge

The healthcare industry is highly regulated and competitive, with overlapping patents often creating hurdles for new entrants. MedVision needed a robust IP strategy to protect its innovation while navigating stringent compliance requirements and potential challenges from established competitors.

Solution

Amped IP provided end-to-end legal and strategic IP support:

• Conducted thorough prior art and freedom-to-operate analyses to ensure patentability and mitigate risks.
• Filed 10 meticulously drafted patent applications covering imaging methods, hardware, and software integration.
• Secured trademarks for the device’s branding to establish market differentiation.
• Developed a licensing model for hospitals and healthcare providers to adopt the technology globally.

Results

MedVision successfully obtained seven patents within 18 months, securing its foothold in the healthcare market. The company’s innovations attracted $75 million in funding from venture capitalists and facilitated adoption by 200 hospitals worldwide, generating an additional $25 million in annual revenue.